Diet Soda is linked to Belly Fat: Study

If you are a soda lover, it could be really sad for you to know that diet soda could make you fat. According to a new study conducted by researchers from the University of Texas Health Science Center, an individual who drinks soda gains three times as much waist as a non-drinker.

The study, published in Journal of the American Geriatrics Society, studied the effects of drinking diet sodas regularly. The study had included seniors or those who were already 65 years old and above.

Zydus Cadila Launches Generic Version of Gilead Sciences’ Hepatitis C drug in India

Pharmaceutical companies across the globe have been spending lot of money in research to find out effective treatments for Hepatitis C. In India, more than 10 million people suffer from Hepatitis C, which was earlier considered to be an incurable problem.

Today, Zydus Cadila has launched a generic version of Gilead Sciences’ Hepatitis C drug Sofosbuvir in India. The drug has been launched under the brand name ‘SoviHep’. Both the companies, Zydus and Gilead Sciences, have signed a non-exclusive licensing agreement.

As per the agreement, manufacturing of Gilead Sciences’ Hepatitis C drug Sofosbuvir can be done and also allows the distribution of fixed-dose combination of ledipasvir/sofosbuvir in 91 countries even in India.

Social Isolation causes premature death: Study

A new study conducted by psychologists at Brigham Young University has revealed about the concept of a healthy life.

According to the researchers, social isolation and solitude can be a cause of premature death. Although older people are more prone to feeling lonely and possess a higher risk of mortality, social isolation and solitude can also cause early death in people who are less than 65 years old.

Other studies conducted on the same issue indicated that for sound emotional health, social interaction is important as it improves physical health on a physiological level.

Glaxo’s asthma treatment under review

According to Reuters, GlaxoSmithKline Plc’s new respiratory treatment for chronic breathing problems is being reviewed to ensure the safety of the drug over long term use to treat asthma patients.

According to the US Food and Drugs Administration (FDA), they are conducting review of the treatment and are also carrying out the discussion on approval of the combination treatment, Breo Ellipta.

The agency has already approved the inhaled drug combination of vilanterol and corticosteroid for treatment of chronic obstructive pulmonary disease, which is a breathing disability. It becomes severe over time and generally smokers are only affected by it.

Breastfeeding may Boost Baby’s IQ

A long-term study has indicated an association between breastfeeding and intelligence. The research was done in Brazil, where the researchers traced around 3,500 babies, from all walks of life, and found that those who had been breastfed for longer went on to score higher on IQ tests as adults.

The experts have said that the results, while not convincing, have appeared to back current advice that babies should be completely breastfed for six months. But still, they mentioned that the mothers should have a choice about whether or not to do it.

Breast Biopsy is Best Option for Diagnosing Cancer, still Women should Obtain Second Opinion

It seems that a breast biopsy has become a protocol whenever screening tests indicates towards the present of lump or any other signs hinting cancer. In fact, more number of women is advised to undergo biopsies due better breast cancer screening tools.

Now, it is being said that the procedure can leave a room for doubt. In biopsy, a sample tissue is taken and sent for analysis to the research lab. The specialists then find out the presence of abnormal cells in the sample or the tissue is benign.

A research by University of Washington involved more than 100 pathologists in the United States. Lead researcher Joann Elmore said that only a few of them were able to assess more than 230 tissue samples for biopsy.

Pages

News in Focus

Adani Ports & SEZ Share Price Target at Rs 2,130: Motilal Oswal Research

Motilal Oswal has reiterated its BUY rating on Adani Ports & SEZ, holding a target of Rs 2,130 against a current price of Rs 1,694 — an upside of about 26 percent.

Lenskart Solutions Share Price Target at Rs 850: ICICI Securities

ICICI Securities has initiated coverage on Lenskart Solutions with a BUY rating and a 12-month target of Rs 850, implying about 23 percent upside from the current price of Rs 693.

HDFC AMC Share Price Target at Rs 3,200: Motilal Oswal Research

Motilal Oswal has reiterated its BUY rating on HDFC Asset Management Company after the fund house's analyst meet, holding a target of Rs 3,200 against a current price of Rs 2,447 — an upside of abo

LG Electronics India Share Price Target at Rs 1,925: Axis Direct

Axis Direct has reiterated its BUY call on LG Electronics India with an unchanged 12-month target of Rs 1,965, roughly 19 percent above the prevailing Rs 1,646.

Raymond Realty Share Price Target at Rs 700: ICICI Direct

ICICI Direct has initiated coverage on Raymond Realty with a Buy rating and a net-asset-value-based target of Rs 700, implying roughly 23 percent upside from the prevailing Rs 568.

Apeejay Surrendra Park Hotels Share Price Target at Rs 156:Prabhudas Lilladher Research

Prabhudas Lilladher has retained its BUY rating on Apeejay Surrendra Park Hotels after a management meeting, holding a sum-of-the-parts target of Rs 156 against a current price of Rs 112 — an upsid